SLC5A2 and type 1 diabetes mellitus: Therefore, we anticipated that our first PN experiment, in non‐T1DM rats, would demonstrate positive relationships not only between MABP and sodium excretion, but also MABP and glycosuria when SGLT2 was inhibited with dapagliflozin.